Literature DB >> 21558789

Breast cancer stem-like cells show dominant homologous recombination due to a larger S-G2 fraction.

Osama Al-Assar1, Tine Mantoni, Serena Lunardi, Guy Kingham, Thomas Helleday, Thomas B Brunner.   

Abstract

The concept of cancer stem cells is generally accepted in different malignancies. We have previously shown that the MDA-MB231 breast cancer cells were more radiation resistant when sorted for the two stem cell markers CD24 and ESA. In this study, we examined a possible mechanism that might underlie this phenotype by looking at cell cycle profile and the effect this has on DNA repair pathways. The cell cycle profile showed that there were more CD24(-) ESA(+) sorted MDA-MB231 cells in the S- and G(2)-phases compared with the unsorted cells, 60 and 38% respectively. Cyclin D and E protein levels supported the cell cycle profile and highlighted the possible involvement of homologous recombination (HR) repair in the radioresistant phenotype. To further support this, CD24(-) ESA(+) sorted MDA-MB231 cells demonstrated statistically significant more RAD51 and less γ-H2AX foci 2 h post 4Gy ionising radiation, compared with the unsorted population. Inhibition of the HR pathway effectively sterilised the CD24(- ) ESA(+) sorted MDA-MB231 cells but had no effect on the unsorted cells or MDA468 control breast cancer cell line. Although the changes we saw were specific to MDA-MB231, these results merit further investigation and can be crucial in identifying a mechanism responsible for cancer stem cells treatment resistance in primary tumors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21558789     DOI: 10.4161/cbt.11.12.15699

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  16 in total

1.  Homologous recombination mediates S-phase-dependent radioresistance in cells deficient in DNA polymerase eta.

Authors:  Nils H Nicolay; Rebecca Carter; Stephanie B Hatch; Niklas Schultz; Remko Prevo; W Gillies McKenna; Thomas Helleday; Ricky A Sharma
Journal:  Carcinogenesis       Date:  2012-07-20       Impact factor: 4.944

2.  RAD51 potentiates synergistic effects of chemotherapy with PCI-24781 and cis-diamminedichloroplatinum on gastric cancer.

Authors:  Wei-Ling He; Yu-Huang Li; Wei-Jian Hou; Zun-Fu Ke; Xin-Lin Chen; Li-Ya Lu; Shi-Rong Cai; Wu Song; Chang-Hua Zhang; Yu-Long He
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 3.  Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors.

Authors:  Liangliang Xu; Chang Zou; Shanshan Zhang; Timothy Shun Man Chu; Yan Zhang; Weiwei Chen; Caining Zhao; Li Yang; Zhiyuan Xu; Shaowei Dong; Hao Yu; Bo Li; Xinyuan Guan; Yuzhu Hou; Feng-Ming Kong
Journal:  J Hematol Oncol       Date:  2022-07-07       Impact factor: 23.168

4.  New paradigms and future challenges in radiation oncology: an update of biological targets and technology.

Authors:  Stanley L Liauw; Philip P Connell; Ralph R Weichselbaum
Journal:  Sci Transl Med       Date:  2013-02-20       Impact factor: 17.956

Review 5.  Pharmacological targets of breast cancer stem cells: a review.

Authors:  Sai Kiran S S Pindiprolu; Praveen T Krishnamurthy; Pavan Kumar Chintamaneni
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-02-23       Impact factor: 3.000

6.  Knockdown of the T-box transcription factor Brachyury increases sensitivity of adenoid cystic carcinoma cells to chemotherapy and radiation in vitro: implications for a new therapeutic principle.

Authors:  Yosuke Kobayashi; Tsuyoshi Sugiura; Ikumi Imajyo; Miyuki Shimoda; Kotaro Ishii; Naonari Akimoto; Naoya Yoshihama; Yoshihide Mori
Journal:  Int J Oncol       Date:  2014-02-06       Impact factor: 5.650

7.  Breast cancer stem cell-like cells are more sensitive to ionizing radiation than non-stem cells: role of ATM.

Authors:  Seog-Young Kim; Juong G Rhee; Xinxin Song; Edward V Prochownik; Douglas R Spitz; Yong J Lee
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

Review 8.  Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs.

Authors:  Che-Hsin Lee; Cheng-Chia Yu; Bing-Yen Wang; Wen-Wei Chang
Journal:  Oncotarget       Date:  2016-01-12

9.  Integrin α6/Akt/Erk signaling is essential for human breast cancer resistance to radiotherapy.

Authors:  Ting Hu; Rui Zhou; Yanxia Zhao; Gang Wu
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

Review 10.  New Findings on Breast Cancer Stem Cells: A Review.

Authors:  Azam Bozorgi; Mozafar Khazaei; Mohammad Rasool Khazaei
Journal:  J Breast Cancer       Date:  2015-12-23       Impact factor: 3.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.